title: Response to: 'Pharmacokinetic/pharmacodynamic properties and efficacy/safety of U-500R from randomized clinical studies'.
authors.affiliation: a Wheaton Franciscan Healthcare - Endocrinology , Wauwatosa , WA , USA.
authors.forename: Adrienne
authors.initials: A
authors.lastname: Barnosky
authors.affiliation: b Loyola University Medical Center Ringgold standard institution - Endocrinology , Maywood , IL , USA.
authors.forename: Lisa
authors.initials: L
authors.lastname: Shah
authors.affiliation: c Edward Hines Junior VA Hospital Ringgold standard institution - Endocrinology , Hines , IL , USA.
authors.forename: Farah
authors.initials: F
authors.lastname: Meah
authors.affiliation: c Edward Hines Junior VA Hospital Ringgold standard institution - Endocrinology , Hines , IL , USA.
authors.forename: Nicholas
authors.initials: N
authors.lastname: Emanuele
authors.affiliation: d Loyola University Medical Center - Endocrinology , 2160 First Ave Fahey Center room 137, Maywood , IL , USA.
authors.forename: Mary Ann
authors.initials: MA
authors.lastname: Emanuele
authors.affiliation: b Loyola University Medical Center Ringgold standard institution - Endocrinology , Maywood , IL , USA.
authors.forename: Alaleh
authors.initials: A
authors.lastname: Mazhari
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy*; D004304:Dosage Forms; D004339:Drug Compounding / Q000379:methods; D006801:Humans; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics / Q000494:pharmacology; D007328:Insulin / Q000493:pharmacokinetics / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic
chemical_list: D004304:Dosage Forms; D007004:Hypoglycemic Agents; D007328:Insulin